IP Library Granted Patent US 8,138,306
Granted Patent B2
US 8,138,306 · App. 10/499,883 · Granted Mar 20, 2012

Separation method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,138,306
App. No.
10/499,883
Granted
Mar 20, 2012
Kind
B2
Abstract

The present invention relates to a method of separating a compound from a liquid, which method comprises providing a separation matrix comprising at least one uncharged ligand; providing a liquid wherein the compound to be separated is present in a positively charged state; contacting said matrix with said liquid to adsorb the compound; and removing the liquid. The uncharged ligands possess a quadrupole or dipole moment, allowing for a cation-π interaction between the compound and the ligand. The present invention also encompasses the use of a separation matrix, which comprises an uncharged group that possesses a quadrupole or dipole moment, in said method.

Claims (11)

1. A method of separating one or more proteins from an aqueous solution, which method comprises the steps of:

(a) providing a separation matrix including a C═C double bond or a C≡N triple bond or an aromatic group as at least one uncharged ligand;

(b) providing an aqueous solution wherein each protein to be separated is present in a positively charged state;

(c) contacting, under a low ionic strength of less than 0.2 M, said matrix with said aqueous solution for a sufficient period of time to permit adsorption of each protein to the ligand to occur while maintaining each of said protein in a positively charged state;

(d) removing the aqueous solution from the matrix; and

(e) eluting at least one protein from the separation matrix;

wherein each protein to be separated includes one or more basic amino acids, wherein the adsorption of each protein to said ligand is predominated by cation-π interaction and wherein the adsorption during step (c) is performed at a pH<pl, and the desorption during step (e) is performed at a pH>pl.

2. The method of claim 1 , wherein the ligand is coupled to a support via a spacer, which spacer distances the ligand from the support.

3. The method of claim 2 , wherein said spacer includes one or more functionalities capable of interacting with the protein to be separated.

4. The method of claim 1 , wherein the elution is performed by adding an organic solution.

5. The method of claim 1 , wherein said low ionic strength is about 0.1 M.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →